ReviewGynecologic oncology2017
Prevention of venous thromboembolism in gynecologic oncology surgery.
Review in Gynecologic oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.Medicine · 2020Trial
- Different combination strategies for prophylaxis of venous thromboembolism in patients: A prospective multicenter randomized controlled study.Scientific reports · 2018Trial
- Article
- Perioperative inflammation in gynecologic oncology: nursing strategies for enhanced recovery and complication prevention.Frontiers in medicine · 2026Review
- Impact of a multimodal prehabilitation program on postoperative recovery in patients undergoing total laparoscopic hysterectomy and its clinical effects on reducing the risk of venous thromboembolism occurrence.Frontiers in oncology · 2026Article
- Mode of Minimally Invasive Surgery Associated with Venous Thromboembolism Incidence in Gynecologic Cancer Patients.Current oncology (Toronto, Ont.) · 2025Article
- Symptomatic and asymptomatic venous thromboembolism after minimally invasive surgery for gynecological cancers.The journal of obstetrics and gynaecology research · 2025Article
- Venous thromboembolism risk for patients with BMI ≥40 kg/mGynecologic oncology reports · 2025Article
- Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center.Gynecologic oncology reports · 2024Article
- Article
- Review
- Review
- Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.Journal of thrombosis and thrombolysis · 2022Article
- Validation of two risk assessment models for venous thromboembolism in patients undergoing gynecologic surgery.Annals of translational medicine · 2022Article
- Pilot Study of Effects of Intermittent Pneumatic Compression in the Immediate Peri-Operative Period on Hemodynamic Parameters in Patients After Laparoscopic Gynecologic Surgery.Frontiers in surgery · 2022Article
- Impact of pulmonary embolism on morbidity and mortality in patients undergoing pancreatic surgery.Langenbeck's archives of surgery · 2021Article
- Article
- Effect of multimodal analgesia on gynecological cancer patients after radical resection.American journal of translational research · 2021Article
- Hemoglobin matters: Perioperative blood management for oncology patients.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2021Article
- A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score.Research and practice in thrombosis and haemostasis · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.